TY - JOUR
T1 - Recurrent bacteremia and liver abscess caused by Clostridium difficile
AU - Morioka, Hiroshi
AU - Iguchi, Mitsutaka
AU - Kuzuya, Teiji
AU - Mikamo, Hiroshige
AU - Yagi, Tetsuya
N1 - Publisher Copyright:
© 2017 the Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Clostridium difficile bacteremia (CDB) and liver abscess is a quite rare presentation of C. difficile infection. Patients concerns: A 74-year-old male with primary biliary cirrhosis and hepatocellular carcinoma who underwent transarterial chemoembolization (TACE) developed a high fever on post-TACE day 14. Intravenous ceftriaxone and following meropenem were administered, however, his clinical response was poor. On post-TACE day 24, 2 sets of blood culture were taken due to elevation of C-reactive protein levels. Diagnosis: CDB, caused by bacterial translocation. Interventions: Intravenous vancomycin and oral metronidazole were administered for two weeks. Outcomes: One month after recurrent CDB, the patient was re-admitted due to a liver abscess at the same site of TACE. C. difficile was isolated from the liver abscess and the patient received 6 weeks of oral metronidazole treatment. CDB and liver abscess have not recurred since completion of antibiotic treatment. Lessons: The spore-forming ability of C. difficile may contributed to the recurrent CDB episodes and liver abscess formation in necrotic liver tissue following TACE, and long-term metronidazole therapy was considered to be effective to C. difficile liver abscess.
AB - Clostridium difficile bacteremia (CDB) and liver abscess is a quite rare presentation of C. difficile infection. Patients concerns: A 74-year-old male with primary biliary cirrhosis and hepatocellular carcinoma who underwent transarterial chemoembolization (TACE) developed a high fever on post-TACE day 14. Intravenous ceftriaxone and following meropenem were administered, however, his clinical response was poor. On post-TACE day 24, 2 sets of blood culture were taken due to elevation of C-reactive protein levels. Diagnosis: CDB, caused by bacterial translocation. Interventions: Intravenous vancomycin and oral metronidazole were administered for two weeks. Outcomes: One month after recurrent CDB, the patient was re-admitted due to a liver abscess at the same site of TACE. C. difficile was isolated from the liver abscess and the patient received 6 weeks of oral metronidazole treatment. CDB and liver abscess have not recurred since completion of antibiotic treatment. Lessons: The spore-forming ability of C. difficile may contributed to the recurrent CDB episodes and liver abscess formation in necrotic liver tissue following TACE, and long-term metronidazole therapy was considered to be effective to C. difficile liver abscess.
UR - http://www.scopus.com/inward/record.url?scp=85028709838&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028709838&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000007969
DO - 10.1097/MD.0000000000007969
M3 - Article
C2 - 28858131
AN - SCOPUS:85028709838
SN - 0025-7974
VL - 96
JO - Medicine (United States)
JF - Medicine (United States)
IS - 35
M1 - e7969
ER -